FDA Revokes Emergency Use of Covid-19 Vaccines

BACK TO INSIGHTS     Articles

10/1/2025

Effective August 27, 2025, the United States Food and Drug Administration (FDA) has revoked the Emergency Use Authorizations for the Pfizer and Moderna COVID-19 vaccines that were implemented beginning in late 2020. The Emergency Use Authorizations, which were implemented during the height of the COVID-19 pandemic, made the Pfizer and Moderna COVID vaccines easily accessible for nearly all Americans by allowing access to the vaccines without a prescription.

As a result of the revocation of the Emergency Use Authorization, individuals under the age of 65 without a preexisting condition may be required to obtain a valid prescription in order to receive a COVID-19 vaccination.

For more information, contact:
Lani M. Dornfeld, CHPC | 973.403.3136 | ldornfeld@bracheichler.com
Jonathan J. Walzman | 973.403.3120 | jwalzman@bracheichler.com
Andrew M. Kuder | 973.403.3141 | akuder@bracheichler.com

*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

Jonathan J. Walzman

Member
Healthcare Law, Corporate Transactions & Financial Services

973.403.3120 · 973.618.5561 Fax

Related Practices:   Healthcare Law

Related Industry:   Healthcare